Capitainer’s Post

Recent breakthroughs in Alzheimer’s disease (AD) research have reshaped the landscape of diagnostics and treatment. At the forefront of these developments is Henrik Zetterberg, Professor of Neurochemistry at the University of Gothenburg and University of University College London, and one of the world’s leading researchers on biomarkers for neurodegenerative dementias.   Recently, Zetterberg and his team began combining proteomics methods with quantitative dried blood spot and plasma sampling to enhance the accuracy of remote AD biomarker detection. His lab is conducting ongoing studies using the advanced sampling cards Capitainer®SEP10 that separate blood cells during collection, ensuring a precise and quantitative volume. Read the full article “Game-Changer for Alzheimer's Disease Diagnostics” and watch all videos with Professor Zetterberg. https://lnkd.in/djzuzvSw #alzheimers #neurodegenerative #microsampling